3.2.2运动症状及运动并发症比较运动症状及运动并发症比较见表2，IC

3.2.2 Comparison of <br>motor symptoms and motor complications The comparison of motor symptoms and motor complications is shown in Table 2. The ICD group had a higher UPDRSIII score (P=0.011), and there were no statistics on the HY stage and whether there was abnormal movement in the two groups. learning differences. <br>3.2.3 Comparison of <br>medication usage The comparison of medication usage is shown in Table 2. The subjects in the ICD group used a higher proportion of dopamine receptor agonists (P=0.026), the daily dose of sifuro (P=0.034) and the daily dose of levodopa The equivalent dose (P=0.008) was greater. There was no statistical difference between the two groups in terms of whether they took sifuro, amantadine, rasagiline, or the equivalent daily dose of levodopa.

3.2.2 comparison of exercise symptoms and exercise complications<br>The comparison of motor symptoms and motor complications is shown in Table 2. ICD group has higher updrsiii score (P = 0.011). There is no significant difference between the two groups in terms of H-Y stage and whether there are changes.<br>3.2.3 comparison of medication<br>The comparison of medication is shown in Table 2. Subjects in ICD group used higher proportion of dopamine receptor agonists (P = 0.026), daily dose of senfrol (P = 0.034) and daily equivalent dose of levodopa (P = 0.008). There was no significant difference between the two groups in whether they took senfrol, amantadine, resagilan and the daily equivalent dose of levodopa.

3.2.2 Comparison of sports symptoms and sports complications The comparison of sports symptoms and sports complications is shown in Table 2. The ICD group has a higher UPDRSIII score (P=0.011), and there is no statistical difference between the two groups in terms of H-Y stage and whether there is any abnormality. 3.2.3 Comparison of drug use See Table 2 for the comparison of medication. In ICD group, the proportion of dopamine receptor agonists used was higher (P=0.026), the daily dose of Senfluro (P=0.034) and the daily equivalent dose of levodopa (P=0.008). There was no significant difference between the two groups in whether to take Senfuluo, amantadine, rasagiline and the equivalent dose of levodopa per day.